Director, Chief Bus. Development Officer · NovaBridge Biosciences · NovaBridge Biosciences — Restricted Share Units
Side
A
Value
—
Shares
181.3K
Price
—
Executed
Jun 22, 2026
Disclosed
Jun 24, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 22 executedJun 24, 2026 disclosed
NBP · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Cao Sean Wuxiong filed this Form 4 reporting a grant or award of NBP on Jun 22, 2026. It became public on Jun 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Bus. Development Officer
Cao Sean Wuxiongcik:0002109966
Issuer
NovaBridge Biosciencescik:0001778016
Revision history · 0
No field has changed since this record was first ingested.
